Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 78

1.

Quality of survival assessment in European childhood brain tumour trials, for children below the age of 5 years.

Limond J, Thomas S, Bull KS, Calaminus G, Lemiere J, Traunwieser T, van Santen HM, Weiler L, Spoudeas HA, Chevignard M.

Eur J Paediatr Neurol. 2019 Oct 25. pii: S1090-3798(19)30391-5. doi: 10.1016/j.ejpn.2019.10.002. [Epub ahead of print]

PMID:
31753708
2.

Leydig Cell Function in Male Survivors of Childhood Cancer: A Report From the St Jude Lifetime Cohort Study.

Chemaitilly W, Liu Q, van Iersel L, Ness KK, Li Z, Wilson CL, Brinkman TM, Klosky JL, Barnes N, Clark KL, Howell RM, Smith SA, Krasin MJ, Metzger ML, Armstrong GT, Bishop MW, van Santen HM, Pui CH, Srivastava DK, Yasui Y, Hudson MM, Robison LL, Green DM, Sklar CA.

J Clin Oncol. 2019 Nov 10;37(32):3018-3031. doi: 10.1200/JCO.19.00738. Epub 2019 Sep 26.

PMID:
31557085
3.

Hypothalamic-Pituitary Disorders in Childhood Cancer Survivors: Prevalence, Risk Factors and Long-Term Health Outcomes.

van Iersel L, Li Z, Srivastava DK, Brinkman TM, Bjornard KL, Wilson CL, Green DM, Merchant TE, Pui CH, Howell RM, Smith SA, Armstrong GT, Hudson MM, Robison LL, Ness KK, Gajjar A, Krull KR, Sklar CA, van Santen HM, Chemaitilly W.

J Clin Endocrinol Metab. 2019 Dec 1;104(12):6101-6115. doi: 10.1210/jc.2019-00834.

PMID:
31373627
4.

RRAS2 shapes the TCR repertoire by setting the threshold for negative selection.

Martínez-Riaño A, Bovolenta ER, Boccasavia VL, Ponomarenko J, Abia D, Oeste CL, Fresno M, van Santen HM, Alarcon B.

J Exp Med. 2019 Oct 7;216(10):2427-2447. doi: 10.1084/jem.20181959. Epub 2019 Jul 19.

PMID:
31324740
5.

Clinical Importance of Free Thyroxine Concentration Decline After Radiotherapy for Pediatric and Adolescent Brain Tumors.

van Iersel L, Xu J, Potter BS, Conklin HM, Zhang H, Chemaitilly W, van Santen HM, Merchant TE.

J Clin Endocrinol Metab. 2019 Nov 1;104(11):4998-5007. doi: 10.1210/jc.2019-00539.

PMID:
31173083
6.

Incidence of and Risk Factors for Histologically Confirmed Solid Benign Tumors Among Long-term Survivors of Childhood Cancer.

Kok JL, Teepen JC, van der Pal HJ, van Leeuwen FE, Tissing WJE, Neggers SJCMM, Loonen JJ, Louwerens M, Versluys B, van den Heuvel-Eibrink MM, van Dulmen-den Broeder E, Jaspers MMW, van Santen HM, van der Heiden-van der Loo M, Janssens GO, Maduro JH, Bruggink AH, Jongmans MC, Kremer LCM, Ronckers CM; DCOG-LATER Study Group.

JAMA Oncol. 2019 May 1;5(5):671-680. doi: 10.1001/jamaoncol.2018.6862.

PMID:
30920605
7.

Hypogonadism in Children with a Previous History of Cancer: Endocrine Management and Follow-Up.

van Santen HM, van den Heuvel-Eibrink MM, van de Wetering MD, Wallace WH.

Horm Res Paediatr. 2019;91(2):93-103. doi: 10.1159/000495943. Epub 2019 Jan 31. Review.

8.

Long-term effects of radioiodine treatment on salivary gland function in adult survivors of pediatric differentiated thyroid carcinoma.

Selvakumar T, Nies M, Klein Hesselink MS, Brouwers AH, van der Horst-Schrivers ANA, Klein Hesselink EN, Tissing WJE, Vissink A, Links TP, Bocca G, Burgerhof JGM, van Dam EWCM, Havekes B, van den Heuvel-Eibrink MM, Corssmit EPM, Kremer LCM, Netea-Maier RT, van der Pal HJH, Peeters RP, Smit JWA, Plukker JTM, Ronckers CM, van Santen HM.

J Nucl Med. 2018 Nov 30. pii: jnumed.118.212449. doi: 10.2967/jnumed.118.212449. [Epub ahead of print]

9.

Declining free thyroxine levels over time in irradiated childhood brain tumor survivors.

van Iersel L, Clement SC, Schouten-van Meeteren AYN, Boot AM, Claahsen-van der Grinten HL, Granzen B, Sen Han K, Janssens GO, Michiels EM, van Trotsenburg ASP, Vandertop WP, van Vuurden DG, Caron HN, Kremer LCM, van Santen HM.

Endocr Connect. 2018 Dec;7(12):1322-1332. doi: 10.1530/EC-18-0311.

10.

Pathophysiology and Individualized Treatment of Hypothalamic Obesity Following Craniopharyngioma and Other Suprasellar Tumors: A Systematic Review.

van Iersel L, Brokke KE, Adan RAH, Bulthuis LCM, van den Akker ELT, van Santen HM.

Endocr Rev. 2019 Feb 1;40(1):193-235. doi: 10.1210/er.2018-00017.

PMID:
30247642
11.

Improving Male Reproductive Health After Childhood, Adolescent, and Young Adult Cancer: Progress and Future Directions for Survivorship Research.

Kenney LB, Antal Z, Ginsberg JP, Hoppe BS, Bober SL, Yu RN, Constine LS, van Santen HM, Skinner R, Green DM.

J Clin Oncol. 2018 Jul 20;36(21):2160-2168. doi: 10.1200/JCO.2017.76.3839. Epub 2018 Jun 6. Review.

PMID:
29874140
12.

Endocrine Late Effects in Childhood Cancer Survivors.

Chemaitilly W, Cohen LE, Mostoufi-Moab S, Patterson BC, Simmons JH, Meacham LR, van Santen HM, Sklar CA.

J Clin Oncol. 2018 Jul 20;36(21):2153-2159. doi: 10.1200/JCO.2017.76.3268. Epub 2018 Jun 6. Review.

PMID:
29874130
13.

Management and consequences of postoperative fluctuations in plasma sodium concentration after pediatric brain tumor surgery in the sellar region: a national cohort analysis.

Kruis RWJ, Schouten-van Meeteren AYN, Finken MJJ, Oostdijk W, van Trotsenburg ASP, Boot AM, Claahsen-van der Grinten HL, van Lindert EJ, Han KS, Hoving EW, Michiels EMC, van Santen HM.

Pituitary. 2018 Aug;21(4):384-392. doi: 10.1007/s11102-018-0886-2.

14.

Low FT4 Concentrations around the Start of Recombinant Human Growth Hormone Treatment: Predictor of Congenital Structural Hypothalamic-Pituitary Abnormalities?

van Iersel L, van Santen HM, Zandwijken GRJ, Zwaveling-Soonawala N, Hokken-Koelega ACS, van Trotsenburg ASP.

Horm Res Paediatr. 2018;89(2):98-107. doi: 10.1159/000486033. Epub 2018 Jan 18.

15.

The development of hypothalamic obesity in craniopharyngioma patients: A risk factor analysis in a well-defined cohort.

van Iersel L, Meijneke RWH, Schouten-van Meeteren AYN, Reneman L, de Win MM, van Trotsenburg ASP, Bisschop PH, Finken MJJ, Vandertop WP, van Furth WR, van Santen HM.

Pediatr Blood Cancer. 2018 May;65(5):e26911. doi: 10.1002/pbc.26911. Epub 2018 Jan 4.

PMID:
29314661
16.

Psychosocial development in survivors of childhood differentiated thyroid carcinoma: a cross-sectional study.

Nies M, Dekker BL, Sulkers E, Huizinga GA, Klein Hesselink MS, Maurice-Stam H, Grootenhuis MA, Brouwers AH, Burgerhof JGM, van Dam EWCM, Havekes B, van den Heuvel-Eibrink MM, Corssmit EPM, Kremer LCM, Netea-Maier RT, van der Pal HJH, Peeters RP, Plukker JTM, Ronckers CM, van Santen HM, van der Horst-Schrivers ANA, Tissing WJE, Bocca G, Links TP.

Eur J Endocrinol. 2018 Mar;178(3):215-223. doi: 10.1530/EJE-17-0741. Epub 2017 Dec 18.

17.

Balancing the benefits and harms of thyroid cancer surveillance in survivors of Childhood, adolescent and young adult cancer: Recommendations from the international Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCareSurFup Consortium.

Clement SC, Kremer LCM, Verburg FA, Simmons JH, Goldfarb M, Peeters RP, Alexander EK, Bardi E, Brignardello E, Constine LS, Dinauer CA, Drozd VM, Felicetti F, Frey E, Heinzel A, van den Heuvel-Eibrink MM, Huang SA, Links TP, Lorenz K, Mulder RL, Neggers SJ, Nieveen van Dijkum EJM, Oeffinger KC, van Rijn RR, Rivkees SA, Ronckers CM, Schneider AB, Skinner R, Wasserman JD, Wynn T, Hudson MM, Nathan PC, van Santen HM.

Cancer Treat Rev. 2018 Feb;63:28-39. doi: 10.1016/j.ctrv.2017.11.005. Epub 2017 Nov 14. Review.

PMID:
29202445
18.

Diastolic Dysfunction is Common in Survivors of Pediatric Differentiated Thyroid Carcinoma.

Klein Hesselink MS, Bocca G, Hummel YM, Brouwers AH, Burgerhof JGM, van Dam EWCM, Gietema JA, Havekes B, van den Heuvel-Eibrink MM, Corssmit EPM, Kremer LCM, Netea-Maier RT, van der Pal HJH, Peeters RP, Plukker JTM, Ronckers CM, van Santen HM, van der Meer P, Links TP, Tissing WJE.

Thyroid. 2017 Dec;27(12):1481-1489. doi: 10.1089/thy.2017.0383.

PMID:
29132262
19.

Childhood Thyroid Function Reference Ranges and Determinants: A Literature Overview and a Prospective Cohort Study.

Önsesveren I, Barjaktarovic M, Chaker L, de Rijke YB, Jaddoe VWV, van Santen HM, Visser TJ, Peeters RP, Korevaar TIM.

Thyroid. 2017 Nov;27(11):1360-1369. doi: 10.1089/thy.2017.0262. Epub 2017 Oct 24. Review.

PMID:
28942709
20.

RE: Incidence and risk factors for secondary malignancy in patients with neuroblastoma after treatment with 131-I-metaiodobenzylguanidine. Huibregtse K et al. European Journal of Cancer 2016. 66:144-152.

Ronckers CM, Tytgat L, van den Heuvel-Eibrink MM, Teepen J, Kremer LCM, Clement S, van Santen HM.

Eur J Cancer. 2017 May;77:21-23. doi: 10.1016/j.ejca.2017.02.019. Epub 2017 Mar 27. No abstract available.

PMID:
28359832
21.

Recommendations for gonadotoxicity surveillance in male childhood, adolescent, and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCareSurFup Consortium.

Skinner R, Mulder RL, Kremer LC, Hudson MM, Constine LS, Bardi E, Boekhout A, Borgmann-Staudt A, Brown MC, Cohn R, Dirksen U, Giwercman A, Ishiguro H, Jahnukainen K, Kenney LB, Loonen JJ, Meacham L, Neggers S, Nussey S, Petersen C, Shnorhavorian M, van den Heuvel-Eibrink MM, van Santen HM, Wallace WH, Green DM.

Lancet Oncol. 2017 Feb;18(2):e75-e90. doi: 10.1016/S1470-2045(17)30026-8. Review. Erratum in: Lancet Oncol. 2017 Apr;18(4):e196.

PMID:
28214419
22.

Pediatric papillary thyroid cancer: current management challenges.

Verburg FA, Van Santen HM, Luster M.

Onco Targets Ther. 2016 Dec 28;10:165-175. doi: 10.2147/OTT.S100512. eCollection 2017. Review.

23.

Long-Term Quality of Life in Adult Survivors of Pediatric Differentiated Thyroid Carcinoma.

Nies M, Klein Hesselink MS, Huizinga GA, Sulkers E, Brouwers AH, Burgerhof JGM, van Dam EWCM, Havekes B, van den Heuvel-Eibrink MM, Corssmit EPM, Kremer LCM, Netea-Maier RT, van der Pal HJH, Peeters RP, Plukker JTM, Ronckers CM, van Santen HM, Tissing WJE, Links TP, Bocca G.

J Clin Endocrinol Metab. 2017 Apr 1;102(4):1218-1226. doi: 10.1210/jc.2016-2246.

PMID:
28001468
24.

Prevalence and Risk Factors of Early Endocrine Disorders in Childhood Brain Tumor Survivors: A Nationwide, Multicenter Study.

Clement SC, Schouten-van Meeteren AY, Boot AM, Claahsen-van der Grinten HL, Granzen B, Sen Han K, Janssens GO, Michiels EM, van Trotsenburg AS, Vandertop WP, van Vuurden DG, Kremer LC, Caron HN, van Santen HM.

J Clin Oncol. 2016 Dec 20;34(36):4362-4370. Epub 2016 Oct 31.

PMID:
27998218
25.

Recommendations for Premature Ovarian Insufficiency Surveillance for Female Survivors of Childhood, Adolescent, and Young Adult Cancer: A Report From the International Late Effects of Childhood Cancer Guideline Harmonization Group in Collaboration With the PanCareSurFup Consortium.

van Dorp W, Mulder RL, Kremer LC, Hudson MM, van den Heuvel-Eibrink MM, van den Berg MH, Levine JM, van Dulmen-den Broeder E, di Iorgi N, Albanese A, Armenian SH, Bhatia S, Constine LS, Corrias A, Deans R, Dirksen U, Gracia CR, Hjorth L, Kroon L, Lambalk CB, Landier W, Levitt G, Leiper A, Meacham L, Mussa A, Neggers SJ, Oeffinger KC, Revelli A, van Santen HM, Skinner R, Toogood A, Wallace WH, Haupt R.

J Clin Oncol. 2016 Oct 1;34(28):3440-50. doi: 10.1200/JCO.2015.64.3288. Epub 2016 Jul 25. Review.

26.

Poorly Controlled Congenital Hypothyroidism due to an Underlying Allgrove Syndrome.

van Tellingen V, Finken MJ, Israëls J, Hendriks YM, Kamp GA, van Santen HM.

Horm Res Paediatr. 2016;86(6):420-424. doi: 10.1159/000446604. Epub 2016 Jun 3.

27.

Pediatric Differentiated Thyroid Carcinoma in The Netherlands: A Nationwide Follow-Up Study.

Klein Hesselink MS, Nies M, Bocca G, Brouwers AH, Burgerhof JG, van Dam EW, Havekes B, van den Heuvel-Eibrink MM, Corssmit EP, Kremer LC, Netea-Maier RT, van der Pal HJ, Peeters RP, Schmid KW, Smit JW, Williams GR, Plukker JT, Ronckers CM, van Santen HM, Tissing WJ, Links TP.

J Clin Endocrinol Metab. 2016 May;101(5):2031-9. doi: 10.1210/jc.2015-3290. Epub 2016 Mar 10.

28.

Endocrine disorders among long-term survivors of childhood head and neck rhabdomyosarcoma.

Clement SC, Schoot RA, Slater O, Chisholm JC, Abela C, Balm AJM, van den Brekel MW, Breunis WB, Chang YC, Davila Fajardo R, Dunaway D, Gajdosova E, Gaze MN, Gupta S, Hartley B, Kremer LCM, van Lennep M, Levitt GA, Mandeville HC, Pieters BR, Saeed P, Smeele LE, Strackee SD, Ronckers CM, Caron HN, van Santen HM, Merks JHM.

Eur J Cancer. 2016 Feb;54:1-10. doi: 10.1016/j.ejca.2015.10.064. Epub 2015 Dec 17.

PMID:
26707591
29.

Intermediate and long-term adverse effects of radioiodine therapy for differentiated thyroid carcinoma--a systematic review.

Clement SC, Peeters RP, Ronckers CM, Links TP, van den Heuvel-Eibrink MM, Nieveen van Dijkum EJ, van Rijn RR, van der Pal HJ, Neggers SJ, Kremer LC, van Eck-Smit BL, van Santen HM.

Cancer Treat Rev. 2015 Dec;41(10):925-34. doi: 10.1016/j.ctrv.2015.09.001. Epub 2015 Sep 10. Review.

PMID:
26421813
30.

Changes in body mass index in long-term childhood cancer survivors.

van Santen HM, Geskus RB, Raemaekers S, van Trotsenburg AS, Vulsma T, van der Pal HJ, Caron HN, Kremer LC.

Cancer. 2015 Dec 1;121(23):4197-204. doi: 10.1002/cncr.29614. Epub 2015 Aug 19.

31.

[Multiple endocrine neoplasia type 2B].

Pijnenburg-Kleizen KJ, van Santen HM, Koolen DA, Claahsen-van der Grinten HL.

Ned Tijdschr Geneeskd. 2015;159:A7719. Dutch.

PMID:
25944066
32.

Quality of life and clinical outcome after thyroid surgery in children: A 13 years single center experience.

Stokhuijzen E, van der Steeg AF, Nieveen van Dijkum EJ, van Santen HM, van Trotsenburg AS.

J Pediatr Surg. 2015 Oct;50(10):1701-6. doi: 10.1016/j.jpedsurg.2015.02.067. Epub 2015 Mar 13.

PMID:
25805004
33.

Is outcome of differentiated thyroid carcinoma influenced by tumor stage at diagnosis?

Clement SC, Kremer LC, Links TP, Mulder RL, Ronckers CM, van Eck-Smit BL, van Rijn RR, van der Pal HJ, Tissing WJ, Janssens GO, van den Heuvel-Eibrink MM, Neggers SJ, van Dijkum EJ, Peeters RP, van Santen HM.

Cancer Treat Rev. 2015 Jan;41(1):9-16. doi: 10.1016/j.ctrv.2014.10.009. Epub 2014 Nov 11. Review.

PMID:
25544598
34.

Effects of T3 treatment on brown adipose tissue and energy expenditure in a patient with craniopharyngioma and hypothalamic obesity.

van Santen HM, Schouten-Meeteren AY, Serlie M, Meijneke RW, van Trotsenburg AS, Verberne H, Holleman F, Fliers E.

J Pediatr Endocrinol Metab. 2015 Jan;28(1-2):53-7. doi: 10.1515/jpem-2014-0337.

PMID:
25514327
35.

Long-term efficacy of current thyroid prophylaxis and future perspectives on thyroid protection during 131I-metaiodobenzylguanidine treatment in children with neuroblastoma.

Clement SC, van Rijn RR, van Eck-Smit BL, van Trotsenburg AS, Caron HN, Tytgat GA, van Santen HM.

Eur J Nucl Med Mol Imaging. 2015 Apr;42(5):706-15. doi: 10.1007/s00259-014-2967-4. Epub 2014 Dec 16.

PMID:
25512056
36.

Hypothalamic obesity after treatment for craniopharyngioma: the importance of the home environment.

Meijneke RW, Schouten-van Meeteren AY, de Boer NY, van Zundert S, van Trotsenburg PA, Stoelinga F, van Santen HM.

J Pediatr Endocrinol Metab. 2015 Jan;28(1-2):59-63. doi: 10.1515/jpem-2014-0338.

PMID:
25381948
37.

[A practical algorithm for polydipsia in children].

Prop S, van Santen HM, Jöbsis JJ, Kamp G.

Ned Tijdschr Geneeskd. 2014;158:A7595. Review. Dutch.

PMID:
25269635
38.

High prevalence of early hypothalamic-pituitary damage in childhood brain tumor survivors: need for standardized follow-up programs.

Clement SC, Meeteren AY, Kremer LC, van Trotsenburg AS, Caron HN, van Santen HM.

Pediatr Blood Cancer. 2014 Dec;61(12):2285-9. doi: 10.1002/pbc.25176. Epub 2014 Aug 17.

PMID:
25131941
39.

[Primary amenorrhoea and macrocephaly].

Garrelfs MR, Vandertop WP, van Santen HM.

Ned Tijdschr Geneeskd. 2014;158:A7125. Dutch.

PMID:
25004780
40.

Receptor Pre-Clustering and T cell Responses: Insights into Molecular Mechanisms.

Castro M, van Santen HM, Férez M, Alarcón B, Lythe G, Molina-París C.

Front Immunol. 2014 Apr 30;5:132. doi: 10.3389/fimmu.2014.00132. eCollection 2014. Review.

41.

Cognate peptide-MHC complexes are expressed as tightly apposed nanoclusters in virus-infected cells to allow TCR crosslinking.

Ferez M, Castro M, Alarcon B, van Santen HM.

J Immunol. 2014 Jan 1;192(1):52-8. doi: 10.4049/jimmunol.1301224. Epub 2013 Dec 4.

42.

Primary ovarian insufficiency in children after treatment with 131I-metaiodobenzylguanidine for neuroblastoma: report of the first two cases.

Clement SC, Kraal KC, van Eck-Smit BL, van den Bos C, Kremer LC, Tytgat GA, van Santen HM.

J Clin Endocrinol Metab. 2014 Jan;99(1):E112-6. doi: 10.1210/jc.2013-3595. Epub 2013 Dec 4.

PMID:
24187404
43.

Visualization of TCR nanoclusters via immunogold labeling, freeze-etching, and surface replication.

Fiala GJ, Rejas MT, Schamel WW, van Santen HM.

Methods Cell Biol. 2013;117:391-410. doi: 10.1016/B978-0-12-408143-7.00021-9.

PMID:
24143989
44.

Models of self-peptide sampling by developing T cells identify candidate mechanisms of thymic selection.

Bains I, van Santen HM, Seddon B, Yates AJ.

PLoS Comput Biol. 2013;9(7):e1003102. doi: 10.1371/journal.pcbi.1003102. Epub 2013 Jul 25.

45.

Long-term follow-up of the thyroid gland after treatment with 131I-Metaiodobenzylguanidine in children with neuroblastoma: importance of continuous surveillance.

Clement SC, van Eck-Smit BL, van Trotsenburg AS, Kremer LC, Tytgat GA, van Santen HM.

Pediatr Blood Cancer. 2013 Nov;60(11):1833-8. doi: 10.1002/pbc.24681. Epub 2013 Jul 6.

PMID:
23832530
46.

[Children with obesity and declining linear growth curve: Cushing's disease?].

van Wezel EM, van Santen HM, van Furth W, Reneman L, Bisschop PH, van Trotsenburg AS.

Ned Tijdschr Geneeskd. 2012;156(51):A4677. Dutch.

PMID:
23249505
47.

Response to teszler.

van Santen HM, Tytgat GA, van de Wetering MD, van Eck-Smit BL, Hopman SM, van der Steeg AF, Nieveen van Dijkum EJ, van Trotsenburg AS.

Thyroid. 2013 Feb;23(2):249. doi: 10.1089/thy.2012.0149.rs. Epub 2012 Nov 27. No abstract available.

PMID:
23185983
48.

Final height in survivors of childhood cancer compared with Height Standard Deviation Scores at diagnosis.

Knijnenburg SL, Raemaekers S, van den Berg H, van Dijk IW, Lieverst JA, van der Pal HJ, Jaspers MW, Caron HN, Kremer LC, van Santen HM.

Ann Oncol. 2013 Apr;24(4):1119-26. doi: 10.1093/annonc/mds580. Epub 2012 Nov 8.

49.

Sleep disorders in children after treatment for a CNS tumour.

Verberne LM, Maurice-Stam H, Grootenhuis MA, Van Santen HM, Schouten-Van Meeteren AY.

J Sleep Res. 2012 Aug;21(4):461-9. doi: 10.1111/j.1365-2869.2011.00971.x. Epub 2011 Oct 1.

50.

Differentiated thyroid carcinoma after 131I-MIBG treatment for neuroblastoma during childhood: description of the first two cases.

van Santen HM, Tytgat GA, van de Wetering MD, van Eck-Smit BL, Hopman SM, van der Steeg AF, Nieveen van Dijkum EJ, van Trotsenburg AS.

Thyroid. 2012 Jun;22(6):643-6. doi: 10.1089/thy.2011.0464. Epub 2012 Apr 23.

PMID:
22524499

Supplemental Content

Loading ...
Support Center